IPP Bureau
Zydus seeks DCGI approval for the use of Pegylated Interferon alpha-2b in treating COVID-19
By IPP Bureau - April 05, 2021
PegIFN in COVID19 has several add-on advantages compared to other anti-viral agents
Tatva Chintan Pharma Chem plans for IPO files DRHP with SEBI
By IPP Bureau - April 05, 2021
TCPCL is the largest and only commercial manufacturer of SDAs for zeolites in India
Reports on GSK Pharmaceuticals by ICICI Securities
By IPP Bureau - April 03, 2021
GSKP announced sale of its newly constructed manufacturing plant at Vemgal, Karnataka to Hetero Labs for a cash consideration of Rs1.8bn
Lonza completes divestment of two sites to NextPharma
By IPP Bureau - April 02, 2021
Strategic divestment of Ploermel and Edinburgh sites will enable NextPharma to benefit from operational synergies and optimize existing expertise and technologies
Piramal Pharma to acquire 100% stake in Hemmo for Rs 775 Cr
By IPP Bureau - April 01, 2021
This acquisition marks PPS’ foray into the development and manufacturing of peptide APIs
Promoters of Lincoln Pharma increases holding by 4.9%
By IPP Bureau - April 01, 2021
The promoter holding in the company has increased to 37.25%, a rise of 4.9% from 32.35% as of 31 March 2020
Our collective decisions will shape the future policy for equitable distribution of vaccine: Dr. Harsh Vardhan
By IPP Bureau - March 31, 2021
India produces 60% of the world’s vaccine
Investment opportunities in India’s healthcare sector: NITI Aayog
By IPP Bureau - March 31, 2021
Report outlines the wide array of investment opportunities in various segments of India’s healthcare sector
Bliss GVS Pharma files suit for IPR infringement
By IPP Bureau - March 30, 2021
The company had filed a suit in the High Court of Justice, Ghana
Need for integration of various regulatory agencies : Pharma secretary
By IPP Bureau - March 26, 2021
Integration of various regulatory agencies with a single-window system and putting in place a transparent, stable, predictable and easy to navigate interface.
COVID-19 drug Remdesivir now priced at Rs. 899
By IPP Bureau - March 25, 2021
Zydus has made its brand of Remdesivir, Remdac more affordable at Rs. 899 for a 100 mg lyophilized injection.
LupinLife to promote hand hygiene at Kumbh Mela 2021
By IPP Bureau - March 24, 2021
Lupin will provide five lakh LupiSafe hand sanitizers to policemen and frontline workers deployed at strategic locations
NPPA brings 80 plus medicines under price regulation
By IPP Bureau - March 22, 2021
NPPA also fixed retail price of 76 new drugs in the meeting dated 10th March 2021 to be launched by existing manufacturers including off-patent Anti-diabetic drugs allowing due benefit of patent expiry to the patients.
Merck accelerates expansion plans for single-use products critical to manufacturing vaccines
By IPP Bureau - March 18, 2021
The company will add a single-use assembly production unit at its Life Science Center in Molsheim, France.
Merck brings new renewable energy to the grid through VPPA with Enel Green Power
By IPP Bureau - March 18, 2021
Has signed a 12-year, off-site, virtual power purchase agreement (VPPA) with Enel Green Power